VX-864

Despite Hitting Mid-Stage Trial Endpoint Goal, Vertex Strikes Out Rare Lung Disease Candidate; Stock Tumbles
Yahoo/Benzinga
Fri, 06/11/21 - 10:45 am
Vertex Pharmaceuticals
VX-864
alpha-1 antitrypsin deficiency
clinical trials
Vertex stops work on second rare disease drug after study results disappoint
BioPharma Dive
Thu, 06/10/21 - 11:36 pm
Vertex Pharmaceuticals
VX-864
cystic fibrosis